The impact of sarcopenia on the efficacy of PD-1 inhibitors in non-small cell lung cancer and potential strategies to overcome resistance
Article in Frontiers in Pharmacology (July 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
Article in Frontiers in Immunology (July 2024)
Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor
Article in World Journal of Gastroenterology (February 2024)